Skip to main content Skip to main navigation menu Skip to site footer

A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Detecting Left Ventricular Hypertrophy In Type 2 Diabetes

  • Suriyanti Listin ,
  • Pendrik Tandean ,
  • Andi Makbul Aman ,
  • Syakib Bakri ,
  • Idar Mapanggara ,
  • Andi Alfian Zainuddin ,

Abstract

Background: Type 2 diabetes mellitus is commonly related to asymptomatic ventricular hypertrophy. While echocardiography is the gold standard, electrocardiography (ECG) is a proper diagnostic method that is both practical and cost-effective. ECG may accurately diagnose left ventricular hypertrophy (LVH) with a sensitivity and specificity similar to echocardiography. However, due to the high cost of managing diabetic patients, there is a need for a simple diagnostic tool to detect early cardiovascular complications. This study aimed to compare the diagnostic performance of Cornell and Sokolow Lyon's criteria for detecting LVH in type 2 DM.

Methods: This research is a cross-sectional analysis including 84 participants. The objective is to evaluate the diagnostic accuracy of Cornell voltage and Sokolow's criteria for detecting left ventricular hypertrophy (LVH). The sensitivities and specificities were calculated by constructing a ROC curve to diagnose LVH.

Results: The Cornell voltage criterion demonstrated superior performance compared to the Sokolow Lyon voltage criteria in the examination of the area under the ROC curve. The Cornell voltage criteria demonstrated an enhanced sensitivity of 66.67%, a specificity of 95.24%, and an AUC of 0.814.

Conclusion: The Cornell criteria had better performance sensitivity than the Sokolow-Lyon criteria for detecting LVH in type 2 DM.

References

  1. Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Setiyohadi B, Syam AF. Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi VI. Interna Publishing. 2014. 1–1474 p.
  2. Lv J, Liu Y, Yan Y, Sun D, Fan L. Hypertrophy and Diabetes Is Likely. 2023;1–10.
  3. A Giha H. Correlates and Severity of Left Ventricular Hypertrophy in Type 2 Diabetes Patients in an Afro-Arab-cross Ethnic Community. Cardiology Research and Reports. 2022;4(4):01–9.
  4. Oley MH, Oley MC, Tjandra DE, Sedu SW, Sumarauw ERN, Aling DMR, et al. Hyperbaric oxygen therapy in the healing process of foot ulcers in diabetic type 2 patients marked by interleukin 6, vascular endothelial growth factor, and PEDIS score: A randomized controlled trial study. International Journal of Surgery Open. 2020;27:154–61.
  5. Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Setiyohadi B, Syam AF. Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi VI. Interna Publishing. 2014. 1–1474 p.
  6. Lv J, Liu Y, Yan Y, Sun D, Fan L. Hypertrophy and Diabetes Is Likely. 2023;1–10.
  7. A Giha H. Correlates and Severity of Left Ventricular Hypertrophy in Type 2 Diabetes Patients in an Afro-Arab-cross Ethnic Community. Cardiology Research and Reports. 2022;4(4):01–9.
  8. Kementerian Kesehatan RI. Infodatin tetap produktif, cegah, dan atasi Diabetes Melitus 2020. Pusat Data dan Informasi Kementerian Kesehatan RI. 2020. p. 1–10.
  9. Hidayat B, Ramadani RV, Rudijanto A, Soewondo P, Suastika K, Siu Ng JY. Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia. Value in Health Regional Issues. 2022;28:82–9.
  10. Park JK, Shin JH, Kim SH, Lim Y-H, Kim K-S, Kim SG, et al. A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Left Ventricular Hypertrophy in Korean Patients. Korean Circulation Journal. 2012;42(9):606.
  11. Park JK, Shin JH, Kim SH, Lim Y-H, Kim K-S, Kim SG, et al. A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Left Ventricular Hypertrophy in Korean Patients. Korean Circulation Journal. 2012;42(9):606.
  12. Su FY, Li YH, Lin YP, Lee CJ, Wang CH, Meng FC, et al. A comparison of Cornell & Sokolow-Lyon electrocardiographic criteria for left ventricular hypertrophy in a military male population in Taiwan: The cardiorespiratory fitness & hospitalization events in armed forces study. Cardiovascular Diagnosis and Therapy. 2017;7(3):244–51.
  13. Lv T, Yuan Y, Yang J, Wang G, Kong L, Li H, et al. The association between ECG criteria and Echo criteria for left ventricular hypertrophy in a general Chinese population. Annals of Noninvasive Electrocardiology. 2021;26(5):1–10.
  14. Rodrigues SL, D’Angelo L, Pereira AC, Krieger JE, Mill JG. Revision of the sokolow-lyon-rappaport and cornell voltage criteria for left ventricular hypertrophy. Arquivos Brasileiros de Cardiologia. 2008;90(1):44–51.
  15. Bürger M. VI. Diagnostik. Einführung in die innere Medizin. 2018;544–5.
  16. Schmitt VH, Billaudelle AM, Schulz A, Keller K, Hahad O, Tröbs SO, et al. Disturbed glucose metabolism and left ventricular geometry in the general population. Journal of Clinical Medicine. 2021;10(17).
  17. Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, et al. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study. Circulation. 2006;113(12):1588–96.
  18. Wibisono S. Pedoman Petunjuk Praktis Terapi Insulin pada pasien Diabtes Melitus 2021. pertama. Indonesia: PB Perkeni; 2021. 70 p.
  19. Soelistijo S. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Global Initiative for Asthma. 2021;46.
  20. Haxha S, Pedersen-Bjergaard U, Nielsen JB, Pallisgaard J, Devereux RB, Okin PM, et al. Cornell voltage left ventricular hypertrophy predicts all-cause mortality better than Sokolow-Lyon voltage in patients with and without diabetes – data from 183,749 primary care ECGs. European Heart Journal. 2020;41(Supplement_2):3042.
  21. Su FY, Li YH, Lin YP, Lee CJ, Wang CH, Meng FC, et al. A comparison of Cornell & Sokolow-Lyon electrocardiographic criteria for left ventricular hypertrophy in a military male population in Taiwan: The cardiorespiratory fitness & hospitalization events in armed forces study. Cardiovascular Diagnosis and Therapy. 2017;7(3):244–51.
  22. Galicia-garcia U, Benito-vicente A, Jebari S, Larrea-sebal A. Pathophysiology of Type 2 Diabetes Mellitus. :1–34.
  23. Statement AHAS. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes : A Scientific Statement From the American Heart. 2022.
  24. Schwartz SS, Epstein S, Corkey BE, Grant SFA, Gavin JR, Aguilar RB. The time is right for a new classification system for diabetes: Rationale and implications of the β-cell-centric classification schema. Diabetes Care. 2016;39(2):179–86.
  25. Martín-Timón I. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World Journal of Diabetes. 2014;5(4):444.
  26. Kementerian Kesehatan RI. Infodatin tetap produktif, cegah, dan atasi Diabetes Melitus 2020. Pusat Data dan Informasi Kementerian Kesehatan RI. 2020. p. 1–10.

How to Cite

Listin, S., Tandean, P., Aman, A. M., Bakri, S. ., Mapanggara, I., & Zainuddin, A. A. (2024). A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria for Detecting Left Ventricular Hypertrophy In Type 2 Diabetes. Bali Medical Journal, 13(1), 755–759. https://doi.org/10.15562/bmj.v13i1.5151

HTML
0

Total
0

Share

Search Panel